• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从携带 COL3A1 基因突变的血管性埃勒斯-当洛斯综合征(vEDS)患者中生成两条 iPSC 系。

Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene.

机构信息

Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine, CA, USA; Stanford Cardiovascular Institute, Stanford University School of Medicine, CA, USA; Division of Cardiovascular Medicine, Stanford University School of Medicine, CA, USA.

Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine, CA, USA; Stanford Cardiovascular Institute, Stanford University School of Medicine, CA, USA; Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, CA, USA.

出版信息

Stem Cell Res. 2024 Sep;79:103485. doi: 10.1016/j.scr.2024.103485. Epub 2024 Jun 25.

DOI:10.1016/j.scr.2024.103485
PMID:38944978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11315230/
Abstract

Vascular Ehlers-Danlos Syndrome (vEDS) is an inherited connective tissue disorder caused by COL3A1 gene, mutations that encodes type III collagen, a crucial component of blood vessels. vEDS can be life-threatening as these patients can have severe internal bleeding due to arterial rupture. Here, we generated induced pluripotent stem cell (iPSC) lines from two vEDS patients carrying a missense mutation in the COL3A1 (c.226A > G, p.Asn76Asp) gene. These lines exhibited typical iPSC characteristics including morphology, expression of pluripotency markers, and could differentiate to all three germ layer. These iPSC lines can serve as valuable tools for elucidating the pathophysiology underlying vEDS.

摘要

血管型埃勒斯-当洛斯综合征(vEDS)是一种遗传性结缔组织疾病,由 COL3A1 基因突变引起,该基因突变导致编码血管中重要成分 III 型胶原的蛋白异常。由于动脉破裂,这些患者可能会发生严重的内出血,因此 vEDS 可能危及生命。在这里,我们从两位携带 COL3A1 基因(c.226A>G,p.Asn76Asp)错义突变的 vEDS 患者中生成了诱导多能干细胞(iPSC)系。这些细胞系表现出典型的 iPSC 特征,包括形态、多能性标志物的表达,并能向三个胚层分化。这些 iPSC 系可以作为阐明 vEDS 发病机制的有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d09/11315230/6a808c3e2cbc/nihms-2014049-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d09/11315230/6a808c3e2cbc/nihms-2014049-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d09/11315230/6a808c3e2cbc/nihms-2014049-f0001.jpg

相似文献

1
Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene.从携带 COL3A1 基因突变的血管性埃勒斯-当洛斯综合征(vEDS)患者中生成两条 iPSC 系。
Stem Cell Res. 2024 Sep;79:103485. doi: 10.1016/j.scr.2024.103485. Epub 2024 Jun 25.
2
Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in Exon 10 or 15?外显子跳跃是否是 10 或 15 外显子突变的血管型 Ehlers-Danlos 综合征的可行治疗方法?
Int J Mol Sci. 2024 Aug 13;25(16):8816. doi: 10.3390/ijms25168816.
3
Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C > T (p.Q105*) in the COL3A1 gene.从一名患有血管型埃勒斯-当洛综合征(vEDS)的患者外周血单个核细胞(PBMCs)中生成人类诱导多能干细胞系(IBKMOLi003-A),该患者在COL3A1基因中携带杂合性无义突变c.430C>T(p.Q105*)。
Stem Cell Res. 2024 Mar;75:103321. doi: 10.1016/j.scr.2024.103321. Epub 2024 Jan 26.
4
A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.遗传性血管型埃勒斯-当洛斯综合征患者的主动脉和动脉病理学的多机构经验。
J Vasc Surg. 2019 Nov;70(5):1543-1554. doi: 10.1016/j.jvs.2019.01.069. Epub 2019 May 21.
5
Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics.患者来源的细胞外基质显示 COL3A1 在血管力学中的作用。
Acta Biomater. 2023 Aug;166:346-359. doi: 10.1016/j.actbio.2023.05.015. Epub 2023 May 13.
6
Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.伴有新型错义COL3A1突变的血管型埃勒斯-当洛综合征出现肺部并发症和髂动脉夹层。
Vasc Endovascular Surg. 2018 Feb;52(2):138-142. doi: 10.1177/1538574417745432. Epub 2017 Dec 7.
7
Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.对具有显性负性COL3A1突变的皮肤成纤维细胞进行转录组分析,为血管性埃勒斯-当洛综合征的病因病理学提供了分子层面的见解。
PLoS One. 2018 Jan 18;13(1):e0191220. doi: 10.1371/journal.pone.0191220. eCollection 2018.
8
Splenic artery pathology presentation, operative interventions, and outcomes in 88 patients with vascular Ehlers-Danlos syndrome.88 例血管型埃勒斯-当洛斯综合征患者的脾动脉病变表现、手术干预及结果。
J Vasc Surg. 2023 Aug;78(2):394-404. doi: 10.1016/j.jvs.2023.04.007. Epub 2023 Apr 15.
9
Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.日本血管型埃勒斯-当洛综合征(vEDS,EDSIV)的遗传学方面
Circ J. 2007 Feb;71(2):261-5. doi: 10.1253/circj.71.261.
10
Recurrent pneumothorax and intrapulmonary cavitary lesions in a male patient with vascular Ehlers-Danlos syndrome and a novel missense mutation in the COL3A1 gene: a case report.血管型埃勒斯-当洛斯综合征男性患者的气胸反复发作和肺内空洞性病变,以及 COL3A1 基因的新型错义突变:病例报告。
BMC Pulm Med. 2020 May 29;20(1):149. doi: 10.1186/s12890-020-1164-4.

引用本文的文献

1
Human-based complex models: their promise and potential for rare disease therapeutics.基于人类的复杂模型:它们在罕见病治疗中的前景与潜力。
Front Cell Dev Biol. 2025 Jan 27;13:1526306. doi: 10.3389/fcell.2025.1526306. eCollection 2025.
2
Generation of induced pluripotent stem cell line from a patient with long COVID.从一位患有长期新冠的患者身上生成诱导多能干细胞系。
Stem Cell Res. 2025 Mar;83:103652. doi: 10.1016/j.scr.2025.103652. Epub 2025 Jan 4.

本文引用的文献

1
Generation of induced pluripotent stem cell line from a patient suffering from arterial calcification due to deficiency of CD73 (ACDC).诱导多能干细胞系的建立,源于一名因 CD73 缺乏导致动脉钙化的患者(ACDC)。
Stem Cell Res. 2024 Mar;75:103285. doi: 10.1016/j.scr.2023.103285. Epub 2023 Dec 19.
2
Endovascular Management of Vascular Complications in Ehlers-Danlos Syndrome Type IV.IV型埃勒斯-当洛综合征血管并发症的血管内治疗
J Clin Med. 2022 Oct 27;11(21):6344. doi: 10.3390/jcm11216344.
3
Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.
使用诱导多能干细胞进行的体外临床试验表明,洛伐他汀可改善LMNA心肌病中的内皮功能障碍和细胞间相互作用。
Sci Transl Med. 2020 Jul 29;12(554). doi: 10.1126/scitranslmed.aax9276.
4
Vascular Ehlers-Danlos Syndrome: Long-Term Observational Study.血管型埃勒斯-当洛斯综合征:长期观察研究。
J Am Coll Cardiol. 2019 Apr 23;73(15):1948-1957. doi: 10.1016/j.jacc.2019.01.058.
5
The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome.COL3A1基因的变异类型与血管性埃勒斯-当洛综合征的表型和严重程度相关。
Eur J Hum Genet. 2015 Dec;23(12):1657-64. doi: 10.1038/ejhg.2015.32. Epub 2015 Mar 11.